Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

German approval for phase I/II trial of BNT-162 vaccine program to prevent COVID-19

April 23, 2020

Interleukins rile each other up in reaction to implants

April 23, 2020

New Toll-like receptor 7 agonists discovered at Bristol-Myers Squibb

April 16, 2020

FDA authorizes phase II study of MultiStem cell therapy in trauma patients

April 16, 2020

The next pandemic: speeding development and stretching supplies

April 16, 2020

Positive topline phase I data reported for ADX-629

April 15, 2020

IND application for CS-12192 accepted in China

March 26, 2020

Arena Pharmaceuticals patents S1P1 agonists

March 24, 2020

Phase I data for influenza vaccination with a high-density microarray patch

March 24, 2020

Pfizer reports phase III data on 20-valent pneumococcal conjugate vaccine in vaccine-naive adults

March 19, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...